Your Reliable Partner in Molecular Diagnostic Kit

An in-Vitro Diagnostics Manufacturing and service company. Established since 2012, focusing on molecular diagnostics for oncology and infectious disease.

About Us

PT. KalGen DNA was established in 2012, is a joint venture between PT Bifarma Adiluhung (a subsidiary of PT Kalbe Farma Tbk.) and a Malaysian company, DNA Laboratories Sdn. Bhd., which is a leading provider of genetic screening and molecular diagnostic services and products in Malaysia.

Our commitment to quality and improvement are demostrated by well-trained molecular analyst, certification by WHO LabNet proficiency test, ISO 13485, obtained CPAKB, CDAKB permit from Ministry of Health. We will continue to develop innovative diagnostic kits in the area of personalized healthcare to improve human health and well-being.

Read More

We are Certified Manufacturing Facility to Ensure Quality & Safety

Mission

To Improve Human Health and Well Being through Innovative Diagnostic Kits.

Vision

To be The Most Reliable Partner of High Quality Diagnostic Kits, driven by Innovation and Excellent Management

Our Services

A well-proven way to prevent cervical cancer is to have screening test. Cervical cancer can affect anyone with a cervix who has ever been sexually active.

KalGen DNA as a marketing for cervical cancer screening test, cooperate with collaborator laboratory, encourage anyone with a cervix who has been sexually active to be screened for cervical cancer.

The fact that cervical cancer rarely presents any symptoms in its early stages highlights the importance of regular screening for the disease.

The main goal of cervical screening is to detect and treat precancer before cancer develops.

Our Products

AmpFire HPV Screening HR 16/18 Kit

AmpFire HPV Screening 16/18/HR is an in vitro diagnostic kit (IVD) for isothermal-based nucleic acid amplification with a real time fluorescence detection method to detect the presence of DNA from the Human papillomavirus (HPV) virus genotypes 16, 18, 31, 33, 35, 39 , 45, 51, 52, 53, 56, 58, 59, 66, 68 qualitative, and specific identification of HPV16 and HPV18 subtypes from various types of samples.

MORE INFO

We work with our partners to bring future of healthcare

join with our partnership